SHR-1816

· Beijing Suncadia Pharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-1816, covering 2025-04-20 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects [Phase 1]

See pricing